vs
Pediatrix Medical Group, Inc.（MD）与Walker & Dunlop, Inc.（WD）财务数据对比。点击上方公司名可切换其他公司
Pediatrix Medical Group, Inc.的季度营收约是Walker & Dunlop, Inc.的1.5倍（$493.8M vs $340.0M），Pediatrix Medical Group, Inc.净利率更高（6.8% vs -12.9%，领先19.7%），Walker & Dunlop, Inc.同比增速更快（-0.4% vs -1.7%），过去两年Walker & Dunlop, Inc.的营收复合增速更高（22.1% vs -0.1%）
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
Walker & Dunlop, Inc.是美国乃至全球规模领先的商业地产金融与咨询服务机构，为客户提供覆盖商业地产领域的多元金融解决方案及专业咨询服务，业务辐射全球多个市场，在行业内拥有深厚的资源积累与广泛的市场认可度。
MD vs WD — 直观对比
营收规模更大
MD
是对方的1.5倍
$340.0M
营收增速更快
WD
高出1.3%
-1.7%
净利率更高
MD
高出19.7%
-12.9%
两年增速更快
WD
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $493.8M | $340.0M |
| 净利润 | $33.7M | $-13.9M |
| 毛利率 | — | — |
| 营业利润率 | 9.9% | -17.2% |
| 净利率 | 6.8% | -12.9% |
| 营收同比 | -1.7% | -0.4% |
| 净利润同比 | 10.5% | -131.0% |
| 每股收益（稀释后） | $0.40 | $-0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDWD
| Q4 25 | $493.8M | $340.0M | ||
| Q3 25 | $492.9M | $337.7M | ||
| Q2 25 | $468.8M | $319.2M | ||
| Q1 25 | $458.4M | $237.4M | ||
| Q4 24 | $502.4M | $341.5M | ||
| Q3 24 | $511.2M | $292.3M | ||
| Q2 24 | $504.3M | $270.7M | ||
| Q1 24 | $495.1M | $228.1M |
净利润MDWD
| Q4 25 | $33.7M | $-13.9M | ||
| Q3 25 | $71.7M | $33.5M | ||
| Q2 25 | $39.3M | $34.0M | ||
| Q1 25 | $20.7M | $2.8M | ||
| Q4 24 | $30.5M | $44.8M | ||
| Q3 24 | $19.4M | $28.8M | ||
| Q2 24 | $-153.0M | $22.7M | ||
| Q1 24 | $4.0M | $11.9M |
营业利润率MDWD
| Q4 25 | 9.9% | -17.2% | ||
| Q3 25 | 13.8% | 13.6% | ||
| Q2 25 | 12.8% | 14.5% | ||
| Q1 25 | 7.0% | 2.2% | ||
| Q4 24 | 7.8% | 15.3% | ||
| Q3 24 | 6.6% | 12.8% | ||
| Q2 24 | -31.3% | 10.4% | ||
| Q1 24 | 3.2% | 6.0% |
净利率MDWD
| Q4 25 | 6.8% | -12.9% | ||
| Q3 25 | 14.5% | 9.9% | ||
| Q2 25 | 8.4% | 10.6% | ||
| Q1 25 | 4.5% | 1.2% | ||
| Q4 24 | 6.1% | 13.1% | ||
| Q3 24 | 3.8% | 9.9% | ||
| Q2 24 | -30.3% | 8.4% | ||
| Q1 24 | 0.8% | 5.2% |
每股收益（稀释后）MDWD
| Q4 25 | $0.40 | $-0.41 | ||
| Q3 25 | $0.84 | $0.98 | ||
| Q2 25 | $0.46 | $0.99 | ||
| Q1 25 | $0.24 | $0.08 | ||
| Q4 24 | $0.37 | $1.32 | ||
| Q3 24 | $0.23 | $0.85 | ||
| Q2 24 | $-1.84 | $0.67 | ||
| Q1 24 | $0.05 | $0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $375.2M | $299.3M |
| 总债务越低越好 | $570.5M | — |
| 股东权益账面价值 | $865.9M | $1.7B |
| 总资产 | $2.2B | $5.1B |
| 负债/权益比越低杠杆越低 | 0.66× | — |
8季度趋势，按日历期对齐
现金及短期投资MDWD
| Q4 25 | $375.2M | $299.3M | ||
| Q3 25 | $340.1M | $274.8M | ||
| Q2 25 | $224.7M | $233.7M | ||
| Q1 25 | $99.0M | $181.0M | ||
| Q4 24 | $229.9M | $279.3M | ||
| Q3 24 | $103.8M | $179.8M | ||
| Q2 24 | $19.4M | $208.1M | ||
| Q1 24 | $8.0M | $216.5M |
总债务MDWD
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MDWD
| Q4 25 | $865.9M | $1.7B | ||
| Q3 25 | $890.7M | $1.8B | ||
| Q2 25 | $833.8M | $1.8B | ||
| Q1 25 | $789.2M | $1.7B | ||
| Q4 24 | $764.9M | $1.7B | ||
| Q3 24 | $732.5M | $1.7B | ||
| Q2 24 | $706.5M | $1.7B | ||
| Q1 24 | $856.2M | $1.7B |
总资产MDWD
| Q4 25 | $2.2B | $5.1B | ||
| Q3 25 | $2.2B | $5.8B | ||
| Q2 25 | $2.1B | $4.7B | ||
| Q1 25 | $2.0B | $4.5B | ||
| Q4 24 | $2.2B | $4.4B | ||
| Q3 24 | $2.1B | $4.6B | ||
| Q2 24 | $2.0B | $4.2B | ||
| Q1 24 | $2.2B | $3.8B |
负债/权益比MDWD
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $114.1M | $-664.3M |
| 自由现金流经营现金流 - 资本支出 | — | $-680.1M |
| 自由现金流率自由现金流/营收 | — | -200.0% |
| 资本支出强度资本支出/营收 | — | 4.6% |
| 现金转化率经营现金流/净利润 | 3.39× | — |
| 过去12个月自由现金流最近4个季度 | — | $-2.2B |
8季度趋势，按日历期对齐
经营现金流MDWD
| Q4 25 | $114.1M | $-664.3M | ||
| Q3 25 | $137.3M | $-948.1M | ||
| Q2 25 | $137.2M | $-238.5M | ||
| Q1 25 | $-117.5M | $-281.1M | ||
| Q4 24 | $133.0M | $129.4M | ||
| Q3 24 | $91.8M | $-202.0M | ||
| Q2 24 | $107.0M | $-237.8M | ||
| Q1 24 | $-125.2M | $38.4M |
自由现金流MDWD
| Q4 25 | — | $-680.1M | ||
| Q3 25 | — | $-950.4M | ||
| Q2 25 | — | $-241.0M | ||
| Q1 25 | — | $-284.7M | ||
| Q4 24 | — | $116.4M | ||
| Q3 24 | — | $-204.0M | ||
| Q2 24 | — | $-241.7M | ||
| Q1 24 | — | $35.2M |
自由现金流率MDWD
| Q4 25 | — | -200.0% | ||
| Q3 25 | — | -281.5% | ||
| Q2 25 | — | -75.5% | ||
| Q1 25 | — | -120.0% | ||
| Q4 24 | — | 34.1% | ||
| Q3 24 | — | -69.8% | ||
| Q2 24 | — | -89.3% | ||
| Q1 24 | — | 15.4% |
资本支出强度MDWD
| Q4 25 | — | 4.6% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 1.4% |
现金转化率MDWD
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | -28.34× | ||
| Q2 25 | 3.49× | -7.02× | ||
| Q1 25 | -5.66× | -102.07× | ||
| Q4 24 | 4.36× | 2.89× | ||
| Q3 24 | 4.72× | -7.01× | ||
| Q2 24 | — | -10.49× | ||
| Q1 24 | -31.03× | 3.24× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
WD
暂无分部数据
